SLC38A2 and acute myeloid leukemia: The modest effects on AML cell growth by targeting SLC38A2 alone could be ascribed to functional redundancy with other amino acid transporters that also show WNK1-dependent phosphorylation, such as SLC38A1 and SLC1A5, which have overlapping substrate specificity with SLC38A267,81,82.